ÖÇÄÜÄÉÃ׿×ϵͳ¿ÉÒÔʵÏÖ¶ÔCOVIDµÄµ¥²¡¶¾¿ÅÁ£¿ìËÙ¶¨µã¼ì²â
È«Çò¹Ú×´²¡¶¾´óÁ÷ÐнÒʾÁË¿ìËÙ²¡ÔÌåɸѡµÄ¹Ø¼üÐèÇó¡£È»¶ø£¬Ä¿Ç°¼ì²âRNA²¡¶¾(°üÀ¨µ¼ÖÂCOVIDµÄSARS-CoV-2²¡¶¾)µÄ½ð±ê×¼ÊÇÄæ×ªÂ¼-¾ÛºÏøÁ´·´Ó¦(RT-pCR)¼ì²â¡£ÕâÖÖ·½·¨ËäȻ׼ȷ£¬µ«ËÙ¶ÈÏà¶Ô½ÏÂý£¬×è°ÁË¿ØÖÆÒßÇéËùÐèµÄ¼°Ê±¸ÉÔ¤¡£
ÏÖÔÚ£¬ÓÉ´óÚæ´óѧÁìµ¼µÄ¿ÆÑ§¼Ò¿ª·¢ÁËÒ»ÖÖÖÇÄÜÄÉÃ׿×ϵͳ£¬¿ÉÒÔÓÃÓÚ¼ì²âSARS-CoV-2²¡¶¾¿ÅÁ£¡£Í¨¹ýʹÓûúÆ÷ѧϰ·½·¨£¬¸Ãƽ̨¿ÉÒÔ×¼È·Çø·Öµ¼Ö²»Í¬ºôÎüµÀ¼²²¡µÄÀàËÆ´óСµÄ¹Ú×´²¡¶¾¡£µÚÒ»×÷ÕßMasateru Taniguchi½ÌÊÚ˵:¡°ÎÒÃǵĴ´Ð¼¼Êõ¾ßÓкܸߵÄÁéÃô¶È£¬ÉõÖÁ¿ÉÒÔͨ¹ýµçÁ÷ʶ±ðµ¥¸ö²¡¶¾¿ÅÁ£¡£¡±ÀûÓÃÕâ¸öƽ̨£¬Ñо¿ÈËÔ±Äܹ»Ôڶ̶Ì5·ÖÖÓÄÚͨ¹ýÁÙ´²ÍÙÒºÑù±¾ÊµÏÖ¶ÔSARS-CoV-2µÄ¼ì²âÁéÃô¶ÈΪ90%£¬ÌØÒìÐÔΪ96%¡£
ΪÁËÖÆÔìÕâÖÖÉ豸£¬ÔÚµª»¯¹è±¡Ä¤ÉÏ×ê¿×ÁËÖ±¾¶Ö»ÓÐ300ÄÉÃ×µÄÄÉÃ׿ס£µ±²¡¶¾±»µçÓ¾Á¦À¹ýÄÉÃ׿×ʱ£¬¿ª¿Ú²¿·Ö±»¶ÂÈû¡£ÕâÔÝʱ¼õÉÙÁËÄÉÃ׿×ÄÚµÄÀë×ÓÁ÷¶¯£¬Õâ±»¼ì²âΪµçÁ÷µÄ±ä»¯¡£µçÁ÷×÷Ϊʱ¼äµÄº¯ÊýÌṩÁ˱»·ÖÎöÄ¿±êµÄÌå»ý¡¢½á¹¹ºÍ±íÃæµçºÉµÄÐÅÏ¢¡£È»¶ø£¬Òª½âÊÍÕâЩϸ΢µÄÐźÅ(¿ÉÄÜÖ»Óм¸ºÁ°²)£¬¾ÍÐèÒª»úÆ÷ѧϰ¡£¸ÃÍŶÓʹÓÃÁË40¸öpcrÑôÐÔºÍ40¸öpcrÒõÐÔµÄÍÙÒºÑù±¾À´ÑµÁ·Ëã·¨¡£
¡°ÎÒÃÇÏ£ÍûÕâÏîÑо¿Äܹ»ÔÚ²»ÐèÒªÌáÈ¡RNAµÄÇé¿öÏ£¬¶ÔSARS-CoV-2½øÐпìËٵļ´Ê±»¤ÀíºÍɸѡ²âÊÔ£¬¡±¹È¿ÚÕý½Ý½ÌÊÚ½âÊÍ˵¡£¡°ÕâÑùÒ»ÖÖÓû§ÓѺᢷÇÇÖÈëÐԵķ½·¨¸üÊʺÏÔÚÒ½ÔººÍÈËȺ¾Û¼¯µÄµØ·½½øÐм´Ê±Õï¶ÏºÍɸ²é¡£¡±ÍêÕûµÄ²âÊÔÆ½Ì¨ÓÉ·þÎñÆ÷ÉϵĻúÆ÷ѧϰÈí¼þ¡¢±ãЯʽ¸ß¾«¶ÈµçÁ÷²âÁ¿ÒǺÍÐԼ۱ȸߵİ뵼ÌåÄÉÃ׿×Ä£¿é×é³É¡£Í¨¹ýʹÓÃÒ»ÖÖ»úÆ÷ѧϰµÄ·½·¨£¬Ñо¿ÈËԱϣÍû¸ÃϵͳÄܹ»ÔÚδÀ´ÓÃÓÚ¼ì²âгöÏֵĴ«È¾²¡¡£¸ÃС×éÏ£ÍûÕâÖÖ·½·¨½«³¹µ×¸Ä±ä¹«¹²ÎÀÉúºÍ¼²²¡¿ØÖÆ¡£
Journal Reference:
Masateru Taniguchi, Shohei Minami, Chikako Ono, Rina Hamajima, Ayumi Morimura, Shigeto Hamaguchi, Yukihiro Akeda, Yuta Kanai, Takeshi Kobayashi, Wataru Kamitani, Yutaka Terada, Koichiro Suzuki, Nobuaki Hatori, Yoshiaki Yamagishi, Nobuei Washizu, Hiroyasu Takei, Osamu Sakamoto, Norihiko Naono, Kenji Tatematsu, Takashi Washio, Yoshiharu Matsuura, Kazunori Tomono. Combining machine learning and nanopore construction creates an artificial intelligence nanopore for coronavirus detection. Nature Communications, 2021; 12 (1) DOI: 10.1038/s41467-021-24001-2
Osaka University. "Highly sensitive test for SARS-CoV-2 may enable rapid point-of-care testing for COVID." ScienceDaily. ScienceDaily, 17 June 2021. <www.sciencedaily.com/releases/2021/06/210617103612.htm>.
Osaka University. (2021, June 17). Highly sensitive test for SARS-CoV-2 may enable rapid point-of-care testing for COVID. ScienceDaily. Retrieved June 18, 2021 from www.sciencedaily.com/releases/2021/06/210617103612.htm
Osaka University. "Highly sensitive test for SARS-CoV-2 may enable rapid point-of-care testing for COVID." ScienceDaily. www.sciencedaily.com/releases/2021/06/210617103612.htm (accessed June 18, 2021).